Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Biolase financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.
Revenue
$49.2 M
FY, 2023
CreditSafe Score
?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|
| Revenue | 39.2M | 48.5M | 49.2M |
| Cost of goods sold | 22.7M | 32.6M | 32.4M |
| Gross profit | 16.5M | 15.9M | 16.7M |
| Gross profit margin, % | 42.2% | 32.8% | 34.0% |
| General and administrative expense | 11.3M | 12.3M | 10.2M |
| Operating expense total | 33.0M | 41.2M | 34.7M |
| EBIT | (16.4M) | (25.4M) | (17.9M) |
| EBIT margin, % | -41.9% | -52.4% | -36.5% |
| Interest expense | 2.2M | 2.7M | 2.4M |
| Pre tax profit | (16.1M) | (28.5M) | (20.6M) |
| Income tax expense | 65.0K | 109.0K | 31.0K |
| Net Income | (16.2M) | (28.6M) | (20.6M) |
| EPS | (0.1) | (4.2) | (29.4) |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |